To determine whether MGO-induced depression-like behaviors could be alleviated by treatment with tRES-HESP, we administered tRES-HESP (200 mg/kg) for 8 weeks to ICR mice in the presence or absence of MGO (Figure 6A–C). Here, TMPRSS11A is linked to depressive symptom measurement.